Sale of Listerine Royalties Goes For $1.79M

Discover the incredible mouthwash sale that is netting an investor 6 figures per year
December 2, 2024
Want to invest in the music royalties featured in this article?
Become a Royalty Exchange member.
Start Investing

Imagine earning passive income every time someone buys a bottle of Listerine. This isn’t a fantasy; it’s a reality thanks to royalty investments. Royalty Exchange is a leading online marketplace where you can buy and sell royalties across various asset classes. From iconic music catalogs to unique assets like Listerine sales, Royalty Exchange democratizes access to passive income streams that were once only available to a select few. This blog post analyzes a recent Listerine royalty sale on Royalty Exchange, breaking down the financials, risks, and potential rewards for investors.

What is Royalty Investing?

Royalty investing involves acquiring the right to receive a portion of the ongoing revenue generated by an asset. These assets can range from music copyrights and movie rights to patents and even brand royalties like the Listerine example. When you buy a royalty, you become entitled to a stream of passive income paid out regularly, typically monthly or quarterly.

The Listerine Royalty Sale: A Unique Opportunity

The Royalty Exchange listing for a portion of the Listerine royalties garnered significant interest, attracting 48 offers from 16 different investors. The winning bid of $1,795,000 represented a multiple of 15.71 times the last twelve months' earnings (LTM), highlighting the strong demand for this stable and unique asset.

Why Listerine?

The appeal of the Listerine royalties stems from its remarkable history and contractual strength. The royalty agreement dates back to 1881 and grants a perpetual royalty on global Listerine sales. This agreement's longevity was upheld in a 1959 US federal court ruling, solidifying its legal standing and ensuring continued payments for as long as Listerine is sold.

Financial Performance: A History of Consistent Earnings

The Listerine royalties boast a strong track record of consistent earnings. The listing reported last twelve months' earnings of $114,253, consistent with a three-year average of $114,715. Furthermore, the total earnings since 2009 amount to an impressive $1,354,002, underscoring the long-term value and stability of this asset.

Risk Assessment: Stability and Potential Concerns

The Listerine royalties present a relatively low-risk investment opportunity.

Pros:

  • Globally recognized brand: Listerine is a household name with a history spanning over a century, suggesting continued sales and royalty payments.
  • Legally protected: The royalty agreement's perpetual nature is legally binding and has withstood legal challenges.
  • Diversification: Listerine's presence in the consumer staples sector provides a hedge against economic downturns as demand for essential products like mouthwash remains relatively stable.

Cons:

  • Market competition: While Listerine is a leading brand, competition from other mouthwash brands could impact future sales and royalty payments.
  • Changing consumer preferences: Shifts in consumer preferences towards natural or alternative oral care products could potentially affect Listerine's market share in the long run.

Bidding History: Strong Investor Appetite

The auction's bidding history reveals a fiercely competitive landscape with investors eager to acquire this unique asset. The final sale price was reached after a series of counteroffers and rejected bids. This intense bidding activity demonstrates the high demand for stable and predictable passive income streams, particularly in uncertain economic times.

Why the Winning Bidder May Have Found This Attractive

The winning bidder likely viewed the Listerine royalties as a compelling long-term investment due to its stable income stream, contractual security, and brand recognition. The 15.71x LTM multiple paid for the asset suggests the bidder expects continued growth and consistent returns for years to come.

Get Started with Royalty Investing

Royalty Exchange offers a unique platform for individuals to participate in royalty investing, opening up a world of passive income opportunities previously accessible only to institutional investors. The platform features a diverse range of assets with some going for as little as hundreds of dollars to ones like this which fetch millions of dollars. Some of the most notable artists in the world have song royalties available on Royalty Exchange, with music catalogs by renowned artists like Jay-Z, Jimi Hendrix, Dire Straits, and Ariana Grande to other unique royalty streams.

Creating an account on Royalty Exchange is easy and provides access to thousands of exciting royalty investment opportunities. By browsing active listings, reviewing financial data, and participating in auctions, new investors can explore the potential of royalty investing to diversify their portfolios and generate passive income. On Royalty Exchange you can sign up as an investor and search through thousands of music catalog listings that include producer and songwriter royalties to some of the biggest songs of the past few decades. Discover why song royalties are one of the best investments to grow your wealth in 2024 and download the free Ultimate Guide To Music Royalties to learn everything you need to know about investing in royalties. Invest in music today and reap the benefits of earning passive income from music rights whose value is independent of macroeconomic markets.

Become a Royalty Exchange Member
Sign Up
Get An Instant Catalog Analysis & Valuation
Sign Up
Interested In Royalty Investing?
Sign Up

Investing Update & Analysis

Shrek Music Royalties Auctioned For $533,000 in Heated Bidding War on Royalty Exchange
Explore the auction that saw Shrek music royalties sold to an investor for half a million dollars.
Read Post
A Growing Piece of Standardized Test Royalties Auctioned For $6.5 Million on Royalty Exchange
Discover the wild world of passive income generating royalties and the auction platform allowing anyone to participate.
Read Post
The Best Music Catalog Investments of November 2024
Unveiling the top music catalog sales from November 2024 that investors purchased
Read Post
No items found.